At the time of writing, Bio Green Med Solution Inc [BGMS] stock is trading at $5.29, up 12.08%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The BGMS shares have gain 7.30% over the last week, with a monthly amount drifted -20.57%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
On September 07, 2018, Ladenburg Thalmann initiated with a Buy rating. H.C. Wainwright started tracking the stock assigning a Buy rating and suggested a price target of $5 on October 16, 2015. Roth Capital initiated its recommendation with a Buy and recommended $7 as its price target on February 04, 2010. In a note dated August 12, 2008, Piper Jaffray initiated an Buy rating and provided a target price of $5 on this stock.
For the past year, the stock price of Bio Green Med Solution Inc fluctuated between $3.08 and $597.60. Bio Green Med Solution Inc [NASDAQ: BGMS] shares were valued at $5.29 at the most recent close of the market.
Analyzing the BGMS fundamentals
According to Bio Green Med Solution Inc [NASDAQ:BGMS], the company’s sales were 0.01M for trailing twelve months, which represents an -100.00% plunge.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 4.84 points at the first support level, and at 4.39 for the second support level. However, for the 1st resistance point, the stock is sitting at 5.71, and for the 2nd resistance point, it is at 6.13.
Ratios To Look Out For
It is important to note that Bio Green Med Solution Inc [NASDAQ:BGMS] has a current ratio of 5.77. In addition, the Quick Ratio stands at 5.77. Considering the valuation of this stock, the price to sales ratio is 1184.65, the price to book ratio is 2.31.
Transactions by insiders
Recent insider trading involved Kua Khai Loon, 10% Owner, that happened on Sep 05 ’25 when 19054.0 shares were sold. 10% Owner, Lazar David E. completed a deal on Jul 30 ’25 to sell 6750.0 shares. Meanwhile, Interim CEO Lazar David E. sold 194.63 million shares on Feb 26 ’25.
